D F Florescu

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. Florescu D, Hill L, Sudan D, Iwen P. Leuconostoc bacteremia in pediatric patients with short bowel syndrome: case series and review. Pediatr Infect Dis J. 2008;27:1013-9 pubmed publisher
    ..This article presents 6 new cases of pediatric patients with short bowel syndrome who developed Leuconostoc bacteremia, and compares these cases with those previously reported in the literature...
  2. Florescu D, Islam K, Grant W, Mercer D, Langnas A, Botha J, et al. Incidence and outcome of fungal infections in pediatric small bowel transplant recipients. Transpl Infect Dis. 2010;12:497-504 pubmed publisher
    ..12, 95% CI 0.45, 2.8). Fungal infections occurred in 25% of SBT recipients and C. albicans was the most common species. Intra-abdominal fungal infections occurred earlier (<1 month) than fungemia (>6 months) post transplantation. ..
  3. Florescu D, Hermsen E, Kwon J, Gumeel D, Grant W, Mercer D, et al. Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients?. Pediatr Transplant. 2011;15:718-21 pubmed publisher
    ..32, OR = 1.0). We show a potential role of OHIG treatment for NVE. Resolution of diarrhea and decreased stool output were observed at seven days; no benefit was found for length of hospital stay or hospital cost. ..
  4. Florescu D, Qiu F, McCartan M, Mindru C, Fey P, Kalil A. What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression. Clin Infect Dis. 2012;54:670-80 pubmed publisher
    ..Our results suggest that colistin may be as safe and as efficacious as standard antibiotics for the treatment of VAP. ..
  5. Florescu D, Langnas A, Sandkovsky U. Opportunistic viral infections in intestinal transplantation. Expert Rev Anti Infect Ther. 2013;11:367-81 pubmed publisher
    ..5, 58.2 and 47%, respectively. IT restores organ functions, but it is associated with complications, with infections representing the major cause of morbidity and mortality in this population. ..

Locale

Collaborators

Detail Information

Publications5

  1. Florescu D, Hill L, Sudan D, Iwen P. Leuconostoc bacteremia in pediatric patients with short bowel syndrome: case series and review. Pediatr Infect Dis J. 2008;27:1013-9 pubmed publisher
    ..This article presents 6 new cases of pediatric patients with short bowel syndrome who developed Leuconostoc bacteremia, and compares these cases with those previously reported in the literature...
  2. Florescu D, Islam K, Grant W, Mercer D, Langnas A, Botha J, et al. Incidence and outcome of fungal infections in pediatric small bowel transplant recipients. Transpl Infect Dis. 2010;12:497-504 pubmed publisher
    ..12, 95% CI 0.45, 2.8). Fungal infections occurred in 25% of SBT recipients and C. albicans was the most common species. Intra-abdominal fungal infections occurred earlier (<1 month) than fungemia (>6 months) post transplantation. ..
  3. Florescu D, Hermsen E, Kwon J, Gumeel D, Grant W, Mercer D, et al. Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients?. Pediatr Transplant. 2011;15:718-21 pubmed publisher
    ..32, OR = 1.0). We show a potential role of OHIG treatment for NVE. Resolution of diarrhea and decreased stool output were observed at seven days; no benefit was found for length of hospital stay or hospital cost. ..
  4. Florescu D, Qiu F, McCartan M, Mindru C, Fey P, Kalil A. What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression. Clin Infect Dis. 2012;54:670-80 pubmed publisher
    ..Our results suggest that colistin may be as safe and as efficacious as standard antibiotics for the treatment of VAP. ..
  5. Florescu D, Langnas A, Sandkovsky U. Opportunistic viral infections in intestinal transplantation. Expert Rev Anti Infect Ther. 2013;11:367-81 pubmed publisher
    ..5, 58.2 and 47%, respectively. IT restores organ functions, but it is associated with complications, with infections representing the major cause of morbidity and mortality in this population. ..